Businesses are primarily successful based on how much money they make or their revenue. But while anyone can roughly grasp revenue, what it means and why it’s essential, revenue as a business figure ...
StockStory.org on MSN
Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales
Life sciences company Azenta (NASDAQ:AZTA) reported Q3 CY2025 results , with sales up 5.5% year on year to $159.2 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback